Magnetar Financial LLC 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-19 4:26 pm Purchase |
2021-10-11 | 13D | Adamas Pharmaceuticals, Inc. ADMS |
Magnetar Financial LLC | 3,131,937 6.850% |
3,131,937 (New Position) |
Filing |